Immutep IMMP
NASDAQ IMMP
$3.13 -0.13 (-3.99%)
As of: Oct 22, 2026 · 11:48 AM EDT

Immutep (IMMP) EBIT Margin (2014 - 2017)

Updated

Immutep (IMMP) reported EBIT Margin of -545.26% for the year ended Jun 30, 2026, up 49.74 percentage points from -595.00% a year earlier.

Analysis

Immutep (IMMP) EBIT Margin (2014 - 2017) Analysis & Trends

Dating back to the year ended Jun 30, 2010, Immutep's EBIT Margin record includes 13 years.

  • EBIT Margin has a four-year change of +18415.48 percentage points (years ended Jun 2022 to Jun 2026).
  • The figure for the year ended Jun 30, 2026 ranks as the highest annual EBIT Margin since the year ended Jun 30, 2020.
  • According to Business Quant data, EBIT Margin came in at -595.00% in the year ended Jun 30, 2025 and -18960.74% in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,168.10 Bn 1,136.68 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 643.43 Bn 561.95 Bn 17.26 Bn 28.21%
3 AbbVie 500.92 Bn 474.03 Bn 12.70 Bn 37.86%
4 Merck 360.47 Bn 314.85 Bn 12.21 Bn -3.52%
5 Novartis Ag 302.41 Bn 266.40 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.36 Bn 241.05 Bn 12.86 Bn 20.57%
7 Amgen 241.30 Bn 196.70 Bn 7.24 Bn 34.95%
8 Gilead Sciences 192.97 Bn 167.17 Bn 6.22 Bn -133.21%
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn 28.37%
10 Immutep 22.75 Mn -188.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 -370.98%
Mar 31, 2017 -137.35%
Jun 30, 2016 3,420,144.49%
Mar 31, 2016 -763.62%
Jun 30, 2015 -19,635.70%
Jun 30, 2014 -83,682.43%
API Access

Immutep EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=IMMP&period=max&api_key=YOUR_API_KEY